Loading clinical trials...
Loading clinical trials...
Pilot Study: Single Arm, Multi-site, Open-label Study to Assess the Effectiveness of Peg-IFN-a2b in Decreasing the Levels of Cell-associated Integrated Viral DNA in HIV Chronic Infection
Conditions
Interventions
Pegylated Interferon alpha 2b
Locations
3
United States
AIDS Clinical Trials Unit (ACTU), and Department of Medicine, University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States
Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States
Jonathan Lax Clinic, Philadelphia FIGHT
Philadelphia, Pennsylvania, United States
Start Date
August 7, 2013
Primary Completion Date
March 25, 2015
Completion Date
May 2, 2016
Last Updated
July 6, 2023
NCT06660498
NCT06602622
NCT06185452
NCT06902038
NCT04568603
NCT01511809
Lead Sponsor
The Wistar Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions